Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation. (Q51705716)
Jump to navigation
Jump to search
scientific article published on 13 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation. |
scientific article published on 13 June 2016 |
Statements
Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation (English)
Chen Dai
Fang-Na Lu
Ning Jin
Bo Yang
Chang Gao
Bin Zhao
Jia-Zhao Fu
Shi-Fu Hong
Han-Ting Liang
Li-Hong Chen
Zhi-Shui Chen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference